EDMOND, OKLAHOMA – Qualgen, a leading 503B hormone pellet manufacturer, is excited to announce its participation in the Age Management Medicine Group’s (AMMG) 35th Clinical Applications for Age Management Medicine...
EDMOND, OKLAHOMA – Qualgen, a leading 503B hormone pellet manufacturer, is excited to announce its participation in the Age Management Medicine Group’s (AMMG) 35th Clinical Applications for Age Management Medicine Conference in Houston, Texas. This highly-anticipated event will take place from October 18 - 22.
The AMMG conference offers a unique platform for medical professionals to explore the latest advancements in Age Management Medicine. Over five days, attendees will gain access to the most recent research findings, engaging presentations, and interactive panel discussions with experts in the field.
At Qualgen, we are dedicated to revolutionizing the field of hormone therapy, and we are thrilled to be a part of this exceptional event. Our team welcomes all attendees, whether prospective or current clients, to visit our booth. We look forward to sharing our innovative hormone pellets and discussing how they can be incorporated into your practice.
"We're excited to be a part of this conference, which aligns perfectly with our mission to provide high quality solutions to healthcare professionals,” Nikki Good, Qualgen’s director of sales said.
Make sure to stop by the Qualgen booth to explore the future of hormone therapy and learn how you can enhance your age management medicine practice.
For more information about Qualgen and our revolutionary hormone pellets, please visit www.qualgen.us.
ABOUT QUALGEN: Qualgen, a U.S. based company located in Edmond, Oklahoma, is a global leader in compounding pharmaceutical production. Founded in 2012, Qualgen offers bio-identical hormone replacement pellets, as well as, numerous scientifically advanced compounds in multiple markets around the world.
